RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1993; 70(02): 373-374
DOI: 10.1055/s-0038-1649586
DOI: 10.1055/s-0038-1649586
Letter to the Editor
rHuEPO lncreases Urinary Excretion of Fibrin Degradation Products in Haemodialysed Patients
Weitere Informationen
Publikationsverlauf
Received 19. November 1992
Accepted after revision 22. Februar 1993
Publikationsdatum:
04. Juli 2018 (online)
-
References
- 1 Eschbach R, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end stage renal disease with recombinant human erythropoietin. New Engl J Med 1987; 316: 73-77
- 2 Hirasawa Y. Exercise function and rHuEPO. Jap J Clin Dial 1989; 5: 929-935
- 3 Gareau R, Brisson GR, Ayotte C, Dubé J, Caron C. Erythropoietin doping in athletes: possible detection through measurement of von Willebrand factor and D-dimer activity?. Thromb Haemostas 1992; 68: 487-488
- 4 Moia M, Mannuci PM, Vizzoto L, Casati S, Cattaneo M, Ponticelli C. Improvement in haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 1987; ii: 1227-1229
- 5 Casati S, Passerini P, Campise MR, Graziani G, Cesana B, Perisic M, Ponticelli C. Benefits and risks of protracted treatment with human recombinant ery-thropoietin in patients having haemodialysis. Br Med J 1987; 295: 1017-1020
- 6 Sakakibara K, Nagase M, Takada Y, Kakada A. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis. Thromb Res 1987; 45: 403-411
- 7 Szewczuk J, Mazerska M, Malyszko J, Kalinowski M, Mysliwiec M. Increase in fibrinolytic activity after erythropoietin therapy. Thromb Haemostas 1992; 67: 284